X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5465) 5465
Publication (304) 304
Book Review (112) 112
Book Chapter (23) 23
Dissertation (21) 21
Conference Proceeding (7) 7
Book / eBook (1) 1
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
schizophrenic-patients (4611) 4611
humans (3466) 3466
psychiatry (3087) 3087
male (2485) 2485
female (1916) 1916
adult (1803) 1803
neurosciences (1705) 1705
schizophrenia (1601) 1601
pharmacology & pharmacy (1399) 1399
index medicus (1243) 1243
middle aged (1020) 1020
animals (888) 888
clinical neurology (783) 783
antipsychotic agents - therapeutic use (654) 654
clozapine (647) 647
adolescent (633) 633
schizophrenia - drug therapy (627) 627
haloperidol (616) 616
rats (550) 550
antipsychotic agents - adverse effects (522) 522
schizophrenic psychology (463) 463
psychosis (443) 443
risperidone (439) 439
aged (426) 426
dopamine (417) 417
antipsychotic agents - pharmacology (403) 403
brain (378) 378
psychiatric status rating scales (359) 359
dose-response relationship, drug (351) 351
prepulse inhibition (334) 334
psychology, clinical (334) 334
bipolar disorder (324) 324
psychology (318) 318
prefrontal cortex (310) 310
young adult (307) 307
psychotic disorders - drug therapy (303) 303
olanzapine (300) 300
treatment outcome (298) 298
antipsychotics (297) 297
analysis (286) 286
psychotic disorders - psychology (280) 280
risk factors (277) 277
double-blind (274) 274
depression (264) 264
mental disorders (257) 257
atypical antipsychotics (254) 254
schizophrenia - diagnosis (251) 251
rats, sprague-dawley (247) 247
research (245) 245
antipsychotic drugs (242) 242
neuroleptics (240) 240
analysis of variance (238) 238
tardive-dyskinesia (236) 236
time factors (234) 234
negative symptoms (233) 233
schizophrenia - physiopathology (233) 233
chronic-schizophrenic patients (230) 230
antipsychotic-drugs (226) 226
symptoms (219) 219
neuropsychological tests (218) 218
positron emission tomography (216) 216
disorders (208) 208
haloperidol - pharmacology (207) 207
drugs (199) 199
mice (197) 197
antipsychotic agents - administration & dosage (187) 187
psychotic disorders - diagnosis (184) 184
prevalence (183) 183
behavioral sciences (181) 181
reflex, startle - drug effects (180) 180
surveys and questionnaires (178) 178
severity of illness index (176) 176
clozapine - pharmacology (174) 174
brain - metabolism (173) 173
follow-up (172) 172
clinical-response (168) 168
in-vivo (166) 166
mental disorders - psychology (165) 165
biochemistry & molecular biology (163) 163
clozapine - therapeutic use (162) 162
acoustic stimulation (161) 161
mental disorders - drug therapy (160) 160
rat (160) 160
neurology (159) 159
pharmacokinetics (157) 157
antipsychotic agents - pharmacokinetics (153) 153
article (153) 153
follow-up studies (150) 150
attention (148) 148
brain - drug effects (147) 147
comorbidity (147) 147
animal-model (146) 146
rat-brain (146) 146
risk (146) 146
cognition (145) 145
medicine & public health (145) 145
nucleus-accumbens (145) 145
reflex, startle - physiology (145) 145
double-blind method (143) 143
j ve psychiatry (142) 142
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5054) 5054
German (188) 188
French (74) 74
Japanese (74) 74
Spanish (34) 34
Chinese (23) 23
Russian (21) 21
Italian (11) 11
Korean (9) 9
Polish (5) 5
Turkish (5) 5
Portuguese (3) 3
Danish (1) 1
Dutch (1) 1
Indonesian (1) 1
Slovenian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Schizophrenia Research, ISSN 0920-9964, 2016, Volume 181, pp. 70 - 71
Journal Article
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, ISSN 0271-0749, 07/2019, Volume 39, Issue 4, pp. 419 - 420
Journal Article
Nature Reviews Neuroscience, ISSN 1471-003X, 2014, Volume 15, Issue 10, pp. 655 - 669
Journal Article
AMERICAN JOURNAL OF PSYCHIATRY, ISSN 0002-953X, 07/2010, Volume 167, Issue 7, pp. 763 - 772
Objective: Several lines of evidence suggest that antipsychotic drug efficacy is mediated by dopamine type 2 (D-2) receptor blockade. Therefore, it seems... 
SCHIZOPHRENIC-PATIENTS | CLOZAPINE TREATMENT | DRD2 GENE | PSYCHIATRY | PROMOTER REGION | THERAPEUTIC RESPONSE | HEALTHY-VOLUNTEERS | DOPAMINE-RECEPTORS | POLYMORPHISM | ASSOCIATION | 1ST-EPISODE SCHIZOPHRENIA
Journal Article
British Journal of Psychiatry, ISSN 0007-1250, 1999, Volume 175, Issue 6, pp. 576 - 580
Background People prescribed clozapine for treatment-resistant schizophrenia have mandatory haematological monitoring through a case register for identifying... 
MORTALITY | FOLLOW-UP | SCHIZOPHRENIC-PATIENTS | PSYCHIATRY | AGRANULOCYTOSIS
Journal Article
Acta Psychiatrica Scandinavica, ISSN 0001-690X, 10/2007, Volume 116, Issue s434, pp. 17 - 26
Journal Article
LANCET, ISSN 0140-6736, 05/2003, Volume 361, Issue 9369, pp. 1581 - 1589
Background The clearest advantage of new generation, atypical antipsychotics is a reduced risk of extrapyramidal side-effects (EPS), compared with conventional... 
REMOXIPRIDE | CLOZAPINE | MEDICINE, GENERAL & INTERNAL | CHLORPROMAZINE | METAANALYSIS | SCHIZOPHRENIC-PATIENTS | CONTROLLED TRIALS | EFFICACY | CLINICAL-TRIALS | DRUGS | ZOTEPINE
Journal Article
AMERICAN JOURNAL OF PSYCHIATRY, ISSN 0002-953X, 03/2001, Volume 158, Issue 3, pp. 360 - 369
Objective: Although atypical antipsychotics are becoming the treatment of choice for schizophrenia, what makes an antipsychotic "atypical" is not clear. This... 
CLOZAPINE | POSITRON-EMISSION-TOMOGRAPHY | SCHIZOPHRENIC-PATIENTS | NEGATIVE SYMPTOMS | HALOPERIDOL | PSYCHIATRY | IBZM-SPECT | RAT-BRAIN | SYNAPTIC DOPAMINE | OCCUPANCY | DOUBLE-BLIND PET
Journal Article
AMERICAN JOURNAL OF PSYCHIATRY, ISSN 0002-953X, 09/2007, Volume 164, Issue 9, pp. 1404 - 1410
Objective: Hyperprolactinemia and associated side effects often occur with antipsychotics. The authors investigated the effect of adjunctive treatment with... 
POSITRON-EMISSION-TOMOGRAPHY | HUMAN PLASMA | SCHIZOPHRENIC-PATIENTS | HALOPERIDOL | SAFETY | PSYCHIATRY | SCHIZOAFFECTIVE DISORDER | PROLACTIN LEVELS | RISPERIDONE | PREVALENCE | ANTIPSYCHOTIC MEDICATIONS
Journal Article
Trends in Neurosciences, ISSN 0166-2236, 2013, Volume 37, Issue 2, pp. 85 - 94
Journal Article
Nature Protocols, ISSN 1754-2189, 12/2006, Volume 1, Issue 5, pp. 2277 - 2281
Measurement of cognitive functions is an increasingly important goal for clinicians and researchers. Many neuropsychological test batteries are comprehensive... 
EXECUTIVE FUNCTION | VISUAL-SEARCH | TRAUMATIC BRAIN-INJURY | SCHIZOPHRENIC-PATIENTS | NEUROPSYCHOLOGICAL IMPAIRMENT | PART-B | TEST-B PERFORMANCE | BIOCHEMICAL RESEARCH METHODS | SCHIZOAFFECTIVE DISORDER | BIPOLAR DISORDER | AGE | Humans | Clinical Protocols | Trail Making Test
Journal Article
Journal of Clinical Psychiatry, ISSN 0160-6689, 11/2018, Volume 79, Issue 6
Objective: Tardive dyskinesia (TD) is an antipsychotic-induced movement disorder that typically occurs after long-term exposure to antipsychotic drugs. There... 
DEUTETRABENAZINE | TREATMENT-RESISTANT | 2ND-GENERATION ANTIPSYCHOTICS | SCHIZOPHRENIC-PATIENTS | HALOPERIDOL | PSYCHIATRY | DRUGS | DOUBLE-BLIND | RANDOMIZED CONTROLLED-TRIAL | QUALITY-OF-LIFE | OLANZAPINE | PSYCHOLOGY, CLINICAL
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2009, Volume 106, Issue 42, pp. 17998 - 18003
Journal Article
Nature Reviews Neuroscience, ISSN 1471-003X, 07/2008, Volume 9, Issue 7, pp. 568 - 578